Pexeva Tablets (paroxetine mesylate) - Engage in Living

Legal Notices

This web site is produced by Noven Therapeutics LLC. The content of this site is protected under applicable copyright and trademark laws. Product names are registered trademarks of Noven Therapeutics LLC, its subsidiaries, affiliates, or alliance partners unless otherwise noted. Your use of information on this site is subject to the terms of this section. You may print a single copy of the content for your own personal noncommercial use, provided any copy of these documents that you make retains all copyright or other proprietary notices and any disclaimer contained thereon. The further copying, redistribution or publication of any part of this site is prohibited. If you link to any third-party web sites from this web site, you should follow the copyright provisions of those sites.

Reasonable efforts have been made to provide accurate and current information, but it is not comprehensive in scope. Noven Therapeutics LLC makes no representation as to the availability, accuracy or completeness of the content of this site.

THIS WEB SITE IS PROVIDED "AS IS" AND THE COMPANY MAKES NO REPRESENTATIONS OR WARRANTIES, EITHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR NON-INFRINGEMENT. THE COMPANY DOES NOT WARRANT THAT THE FUNCTIONS CONTAINED IN THE WEB SITE WILL BE UNINTERRUPTED OR ERROR FREE OR THAT THE WEB SITE OR THE SERVER THAT MAKES IT AVAILABLE ARE FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS. SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OF IMPLIED WARRANTIES, SO PART OF THE ABOVE EXCLUSION MAY NOT APPLY TO YOU.

You agree that all access and use of this Web site and its content is at your own risk.

In no event shall Noven Therapeutics LLC, its affiliates, and subsidiaries, and their respective officers, directors, employees, agents, representatives, information providers and licensors, and their respective heirs and assigns be liable for any direct, indirect, incidental, consequential, special exemplary, punitive or other damages, even if informed of the possibility of such damages, resulting from your access to, or inability to access, this site or from your reliance on any information on this site. Noven Therapeutics LLC shall not be liable for any damages or injury resulting from your access to, or inability to access, this site or from your reliance on any information on this site.

Although accessible by others, the product information on the Noven Therapeutics LLC site is intended for use by U.S. residents only. The dissemination of this information may be subject to different medical and regulatory requirements in other countries. This site links to other sites produced by Noven Therapeutics LLC's subsidiaries and affiliates, some of which are outside the U.S. You should not construe anything on this site as a promotion or solicitation for any product or for the use of any product that is not authorized by the laws and regulations of the country where you are located.

This site may contain from time to time information related to various health and medical conditions and their treatment. Such information is provided for educational purposes only and is not meant to be a substitute for the advice provided by a physician or other healthcare professional. You should not use the information contained herein for diagnosing a health problem or disease. You should always consult a physician or healthcare provider for your personal medical needs.

This site may provide links to other web sites maintained by third parties over which Noven Therapeutics LLC has no control. Noven Therapeutics LLC is not responsible for accuracy or any other aspect of the information contained on such sites and shall not be liable for any damages or injury arising from users' access to such sites. Links to other sites are provided only as a convenience to users of our site.

Should any visitor to the Noven Therapeutics LLC site provide information such as questions, comments, suggestions, ideas, or the like through any feedback mechanisms located herein, except as set forth in the Noven Therapeutics Internet Privacy Statement, Noven Therapeutics LLC shall have no obligation of any kind with respect to such information and shall be free to reproduce, use, disclose, and distribute the information to others without limitation.

IMPORTANT SAFETY INFORMATION

Depression is a serious medical condition that in some people can lead to suicidal thoughts. As with any medication, there are benefits and risks. It is important to discuss these with your doctor.

Suicidal thoughts or behaviors and antidepressant drugs

Short-term studies have shown that antidepressants increased the risk of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults. When deciding to use PEXEVA® (paroxetine mesylate) or any other antidepressant in these patients, people must balance the risk with the potential benefit to the patient. Short-term studies did not show an increased risk of suicidality with antidepressants in adults beyond age 24; the risk decreased in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be watched closely to see if their condition worsens, it they have suicidal thoughts, or if they exhibit any unusual changes in behavior. Families and caregivers need to understand that they should watch the patient closely and tell the doctor if they have any concerns. PEXEVA® (paroxetine mesylate) is not approved for use in pediatric patients.

Who should not take PEXEVA®?

It's important for you to know that antidepressant medicines may increase the risk of suicidal thoughts or actions in children, teenagers, and young adults. Please read the accompanying Medication Guide about Antidepressant Medicines, Depression and other Serious Mental Illnesses, and Suicidal Thoughts or Actions. PEXEVA® is not approved for use in children. PEXEVA® is not recommended for use in women who are pregnant or who plan to become pregnant. These women are warned that use of paroxetine during the first 3 months of pregnancy has been shown to increase the risk of severe health problems in the unborn baby. Some of these health problems affect the baby's heart. One recent study has shown that use of several types of SSRIs, including paroxetine, during the last 3 months of pregnancy may cause dangerous lung complications in newborns. For these reasons, women who are pregnant or who plan to become pregnant should discuss other treatment choices with their doctor. Women who are breastfeeding should also talk to their doctor before taking PEXEVA®.

What side effects may occur with PEXEVA®?

With PEXEVA®, side effects are usually mild to moderate. They may become less noticeable or go away completely over time. The most common side effects that have been reported with PEXEVA® include nausea, dry mouth, constipation, decreased appetite, infection, drowsiness, tremor, sweating, muscle weakness, trouble sleeping, abnormal ejaculation, impotence and other male genital disorders, and female genital disorders.

Can I take PEXEVA® with other medicines?

PEXEVA® should not be usued with monoamine oxidase inhibitors (MAOIs), thioridazine, or pimozide. Be sure to tell your doctor if you think you are taking one of these medications. As with other antidepressants, certain medicines must be taken with caution while taking PEXEVA®. These include medications known as triptans. It's important to tell you doctor about any medicines you are taking, including over-the-counter drugs.

Can I drink alcohol while on PEXEVA®

You should avoid drinking alcohol while on PEXEVA®.

Be sure to tell your doctorhow your are feeling.

If you have any questions about PEXEVA®, call your doctor. Be sure to let your doctor know if you notice any unusual changes while taking PEXEVA®. And never stop your medicine or change your dose before speaking with your doctor.

Please see Important Safety Information, including Black Boxed WARNING.

Please see accompanying full Prescribing Information including WARNINGS-Clinical Worsening and Suicide Risk; Usage in Pregnancy: Teratogenic and Nonteratogenic Effects.